Navigation Links
Investigational Data Presented for INTUNIV™ (guanfacine) Extended-Release Tablets When Coadministered With Stimulants Showed ADHD Symptom Improvement in Overall, Morning and Evening Assessments
Date:10/28/2010

nt to patients and their families."

This study was supported by funding from Shire Development Inc.  Dr Timothy Wilens was a speaker for, received grant support from, and is a consultant for Shire.  

*Suboptimal response was defined as treatment with a stable dose of stimulant for at least four weeks with improvement, yet persistence of mild to moderate ADHD symptoms in the opinion of the investigator (defined as an ADHD-RS-IV total score of at least 24, Clinical Global Impressions-Severity of illness scale score of at least three).  Patients with no response to stimulants prior to study enrollment were excluded from participating in this study.

About INTUNIV

INTUNIV™ (guanfacine) Extended-Release Tablets is a nonstimulant approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents ages 6 to 17.  INTUNIV was approved by the US Food and Drug Administration (FDA) in September 2009 and comes in 4 doses—1 mg, 2 mg, 3 mg, and 4 mg.  INTUNIV should be taken once a day.

The active ingredient in INTUNIV is guanfacine.  INTUNIV is not a central nervous system (CNS) stimulant or a controlled substance.  It is not likely to cause dependence or be abused.

Additional information about INTUNIV and Full Prescribing Information are available at www.intunivpro.com.

Indication

INTUNIV is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents ages 6 to 17.  Efficacy was established in two controlled clinical trials (8 and 9 weeks in duration).  The physician electing to use INTUNIV for extended periods should periodically reevaluate its long-term usefulness for the individual patient.

INTUNIV is indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological,
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. 52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin in Improving Glycosylated Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus
2. Repligen Files Investigational New Drug Application with FDA for First Drug Targeting the Core Genetic Defect of Friedreichs Ataxia
3. Aeterna Zentaris: FDA Approves Investigational New Drug (IND) Application for Doxorubicin Targeted Conjugate Compound, AEZS-108, in Bladder Cancer
4. Anavex comments on failure of Pfizer and Medivations Alzheimers investigational drug Dimebon during Phase 3 clinical trials
5. Peoria Clinical Research Center Tests Investigational Drug to Treat Painful Menstrual Cramps
6. Arena Pharmaceuticals Announces Merck Discontinues Development of Investigational Niacin Receptor Agonist Program for Atherosclerosis
7. Investigational Urine NGAL Biomarker Shows Promise to Monitor Cyclosporine Toxicity in Cardiac Transplant Patients
8. New Phase 3 Data Continue to Indicate that Wyeths Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease
9. FDA Accepts Investigational New Drug (IND) Application for Tigris Pharmaceuticals GGTI-2418
10. Medarex Announces Allowance of Investigational New Drug Application for Companys First Antibody-Drug Conjugate, MDX-1203
11. International Robotic Urology Symposium Reports on Benefits of Cooling During Robotic-Assisted Prostate Surgery and Introduces InnerCools New Investigational UroCool System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/19/2014)... 20, 2014 United States Non-Vascular ... GlobalDatas new report, "United States Non-Vascular Stents Market ... the United States Non-Vascular Stents market. The report ... (in units) and average prices (in US dollars) ... Stents and Metal Biliary Stents (Metal Non-Covered Biliary ...
(Date:7/18/2014)... , July 18, 2014  Neogen Corporation (Nasdaq: ... , Neogen,s chief operating officer and president, has resigned, ... work as a consultant going forward on special projects. ... has been in this position since September 2013. On ... James Herbert , who has been Neogen,s chief ...
(Date:7/18/2014)... world is mostly neutral. That is, most of ... The number of electrons in the outer parts of ... of atoms. As one or more electrons are ... a much stronger positive pull from the nucleus. ... size, ensures that those electrons are less vulnerable to ...
(Date:7/18/2014)... 2014  Neurotrope, Inc. (OTCQB: NTRP) today announced that ... Co-Chairmen Charles S. Ramat and Paul ... basis, effective immediately. Messrs. Ramat and Freiman replace Dr. ... Executive Officer of Neurotrope Bioscience, Inc., (a wholly-owned subsidiary ... agreement with Neurotrope Bioscience Inc. terminated as of July ...
Breaking Biology Technology:United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 2United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 3United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 4Highly charged ions 2Highly charged ions 3Highly charged ions 4Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 2Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 3Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 4
... FRANCISCO, CA November 20, 2007 Acclaimed stem cell ... he and his Kyoto University colleagues have successfully reprogrammed ... (ES) cells. Because it circumvents much of the ... from human embryos, this breakthrough, reported in the journal ...
... Nov. 20 China Biopharma,Inc. (OTC Bulletin Board: ... take closer control and to better improve its ... away from the increasingly competitive and,low margin vaccine ... "We plan to take more control on the ...
... 20 ,Exelixis, Inc. (Nasdaq: EXEL ) today ... Taconic Farms, Inc. (Hudson, NY) pursuant to which ... Artemis Pharmaceuticals GmbH,for approximately $20 million, subject to ... research, development and commercialization of,genetically engineered mouse models ...
Cached Biology Technology:Shinya Yamanaka reprograms human adult cells 2China Biopharma, Inc. Announces New Plan of Operation 2Exelixis Sells 80% Stake in Artemis to Taconic 2Exelixis Sells 80% Stake in Artemis to Taconic 3Exelixis Sells 80% Stake in Artemis to Taconic 4
(Date:7/21/2014)... RUSTON, La. Dr. Mark DeCoster, the James ... at Louisiana Tech University, will present as an ... 24-25 at the Biopolis Research and Development Center ... research faculty member in Louisiana Tech,s Institute for ... for 2D and 3D cell and tissue models." ...
(Date:7/21/2014)... of California, Riverside Bourns College of Engineering students have designed ... backyard grill reduces by 70 percent the level of a ... steel carbon plate with an insulated handle can be installed ... grill to allow the plate to slide in and out. ... could sell new grills with the plate already installed. , ...
(Date:7/21/2014)... Terra and Aqua satellites detected 154 hotspots in areas ... and land fires had increased again following a decline ... Sunday,s report was far higher than what had been ... spots. , The hotspots were scattered in six regencies ... coastal areas. Smoke and the related haze it creates ...
Breaking Biology News(10 mins):Louisiana Tech University professor presents at International Bioprinting Congress 2Catching grease to cut grill pollution 2
... might find it progressively harder to navigate the maze of ... short-term exposure to vehicle pollution, mice showed significant brain damage ... The mind-numbing toxin is not an exhaust gas, but ... and weathering of car parts and pavement, according to the ...
... A groundbreaking clinical study of a new method for preventing ... the medical journal Ultrasound in Obstetrics & Gynecology , ... ( The peer-reviewed findings were led by the Perinatology ... the Wayne State University School of Medicine at Hutzel Hospital ...
... (April 6, 2011) -- Most people experience X-ray computed tomography (CT) ... clot. But in the lab of Dr. Quin Liu, PhD., in ... of CT scanners as part of an agriculture study to increase ... went little potted rice plants in an automated facility that could ...
Cached Biology News:Freeway air bad for mouse brain 2Major breakthrough in preventing premature birth announced by NIH/WSU 2Major breakthrough in preventing premature birth announced by NIH/WSU 3Seeing rice with X-rays may improve crop yields 2
The imaging screen-K (Kodak), is a 35 x 43 cm storage phosphor screen that is used for the quantitation and imaging of 32P, 33P, 35S, 14C, and 3H....
The optional fixed lens, 105 mm, is for use with the VersaDoc imaging systems for imaging small samples at high resolution....
The filter 695RDF55 Reflect 635 for the Molecular Imager FX is a band pass filter for Cy5 and Alexa Fluor 635 dyes....
The HQ505, 20 OptiGreen filter for the Molecular Imager FX is a band pass filter used for detection of Cy2 and FITC with 532 nm excitation....
Biology Products: